Pharma, via its PI Health Sciences arm, now contributes 6% of exports. Q1 FY26 showed a 33% sequential jump in pharma revenues. The management aims to be a differentiated CRDMO player over the next ...

Brokerages predict a challenging period for Tata Motors as India PV/CV and JLR volumes decline. Ebitda margins are under ...

Tata Motors is expected to report a weak set of earnings for the June quarter with a sharp fall in consolidated net profit ...

State Bank of India's Q1 FY26 consolidated profit rose 9.7% to Rs 21,201 crore, fueled by strong treasury and forex income.

Jaguar Land Rover's profitability was significantly impacted by tariffs imposed by the US, leading to a 30% drop in Tata ...

ISLAMABAD: The Sensitive Price Index (SPI)-based inflation witnessed nominal increase of 0.05 percent for the week ended ...

Q2 2025 Management View CEO Catherine Eva Spear reported that Q2 delivered "our largest revenue quarter in our history and powered overall results ahead of expectations." She attributed the ...

D-Wave Quantum Inc.'s stock has surged over 2,000%, but weak financials raise concerns. Explore the quantum computing hype vs ...

GERN reported underlying demand growth of 17% for Rytelo in Q2 vs. Q1 and increased use in early lines of therapy. Click here ...

The impact of tariffs and foreign exchange rates squeezes Nikon's profits, despite strong sales of the Z5 II and Z50 II ...

Digital payments company Infibeam reported a 72% surge in revenue to Rs 1,280 crore for Q1 FY26, while its year-on-year ...

R&D expense was $11.7 million for the three months ended June 30, 2025, compared to $7.6 million for the same period in 2024. The increase was primarily driven by higher research, development, ...